Company News in the Life Science Industry

»

Reset 

Significant blood sugar improvement with Xultophy® 100/3.6 compared to insulin glargine U-100 when used as add-on to oral diabetes medications

ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- Xultophy(®) 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL provided superior A1C reduction compared to insulin glargine U-100 (1.94% vs 1.68% respectively; p?0.0001) when used as an add-on to a SGLT-2i (an oral diabetes... Read more ››

By: PR Newswire Association LLC. - 23 Jun 2018
Related companies:  Novo Nordisk Inc.

Gaumard's Growing Family Takes Center Stage at AWHONN '18

MIAMI, June 23, 2018 /PRNewswire/ -- With women's health, obstetric and neonatal nurses taking on ever-greater responsibilities, there's no better time than AWHONN's 2018 annual convention, from today through June 27 in Tampa, to see Gaumard's... Read more ››

By: PR Newswire Association LLC. - 23 Jun 2018
Related companies:  Gaumard Scientific

Real-World Evidence Shows Oral INVOKANA® (canagliflozin) Results in Greater Weight Loss and Treatment Adherence Than Injectable GLP-1 Receptor Agonists in Type 2 Diabetes Patients

TITUSVILLE, N.J. and ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- The Janssen Pharmaceutical Companies of Johnson & Johnson today announced new findings from two real-world studies comparing sodium glucose co-transporter-2 inhibitor (SGLT2i) INVOKANA(®) (canagliflozin) and glucagon-like... Read more ››

By: PR Newswire Association LLC. - 23 Jun 2018

Fractyl Announces Presentation of Key Scientific Research at ADA 2018 Indicating That Modern Diets Durably Alter Duodenal Lining, Highlighting the Intestine's Role in Type 2 Diabetes and NASH

LEXINGTON, Mass. and ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- Fractyl Laboratories Inc. (Fractyl) today announced the presentation of breakthrough research providing the first clear mechanistic link between modern diets and their... Read more ››

By: PR Newswire Association LLC. - 23 Jun 2018
Related companies:  Fractyl Laboratories, Inc.

New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce Potential of Lilly's Ultra Rapid Lispro in People with Type 1 and Type 2 Diabetes

INDIANAPOLIS, June 23, 2018 /PRNewswire/ -- Eli Lilly and Company's (NYSE: LLY) ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1 and type 2 diabetes, according to results from three phase 1b studies evaluating URLi compared to Humalog(®).... Read more ››

By: PR Newswire Association LLC. - 23 Jun 2018
Related companies:  Eli Lilly and Company

Jardiance® reduced risk of kidney disease progression in adults with type 2 diabetes and established cardiovascular (CV) disease independent of control of conventional CV risk factors

RIDGEFIELD, Conn. and INDIANAPOLIS, June 23, 2018 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced findings from two new analyses of the landmark EMPA-REG OUTCOME(®) trial, presented at the 78(th) American Diabetes Association (ADA) Scientific Sessions(®).... Read more ››

By: PR Newswire Association LLC. - 23 Jun 2018
Related companies:  Eli Lilly and Company

Oral Semaglutide Demonstrated Significant Reduction in Blood Sugar vs Placebo in PIONEER 1 Trial

ORLANDO, Florida, June 23, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 23 Jun 2018
Related companies:  Novo Nordisk Inc.

Artificial Intelligence-Powered Sugar.IQ(TM) Diabetes Management App Developed by Medtronic and IBM Watson Health Now Commercially Available

Read more ››
By: Nasdaq / GlobenewsWire - 23 Jun 2018

TiGenix: Transparency notification pursuant to Article 14 of the Law of May 2, 2007

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

DBV Technologies Announces Results of its 2018 Ordinary and Extraordinary General Meeting and the Appointment of Joan Schmidt as Executive Vice President, General Counsel

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Imagin Provides Further Detail on Kilmer Lucas Engagement

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Altimmune Restructures Financing Agreement

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Analogic Announces Completion of Acquisition by an Affiliate of Altaris Capital Partners

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

EncounterCare Solutions Inc. Announces CyberFuels New fuel shipments commence in Quebec, Canada

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Axiom Real-Time Metrics Exhibiting at DIA Global Annual Meeting in Boston

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Matrix Medical Network to Present at 2018 RISE Quality Leadership Summit

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Cytori Therapeutics Reminds Investors of Today’s Deadline to be a Shareholder of Record

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

ALPHA PRO TECH, LTD. ANNOUNCES ADDITIONAL $2 MILLION EXPANSION TO SHARE REPURCHASE PROGRAM

Read more ››
By: Nasdaq / GlobenewsWire - 22 Jun 2018

Nanotera Group Launches Powerful Plant Based Surfactants for the Oil Industry

LONDON, June 22, 2018 /PRNewswire/ -- Nanotera Group has introduced higher quality, plant-based solutions to replace chemical and hazardous products in the oil & gas industry. Dedicated to protecting the environment, Nanotera now supplies powerful cleaning agents that perform at record times,... Read more ››

By: PR Newswire Association LLC. - 22 Jun 2018

Biotech's Making Great Progress

LAS VEGAS, June 22, 2018 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Jun 2018
Related companies:  Caladrius Biosciences, Inc | NEUROMETRIX, INC. | Verastem Inc. | Stemline Therapeutics, Inc.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Explore our database of over 50,000 companies